G. Barba, C. Matteucci, and G. Girolomoni, Comparative genomic hybridization identifies 17q11.2???q12 duplication as an early event in cutaneous T-cell lymphomas, Cancer Genetics and Cytogenetics, vol.184, issue.1, pp.48-51, 2008.
DOI : 10.1016/j.cancergencyto.2008.03.007

B. Bellei, A. Pacchiarotti, M. Perez, and T. Faraggiana, Frequent ??-catenin overexpression without exon 3 mutation in cutaneous lymphomas, Modern Pathology, vol.83, issue.10, pp.1275-12813, 2004.
DOI : 10.1002/ijc.10719

URL : http://www.nature.com/modpathol/journal/v17/n10/pdf/3800181a.pdf

S. Blume, R. Snyder, and R. Ray, Mithramycin inhibits SP1 binding and selectively inhibits transcriptional activity of the dihydrofolate reductase gene in vitro and in vivo., Journal of Clinical Investigation, vol.88, issue.5, pp.1613-1621, 1991.
DOI : 10.1172/JCI115474

J. Campbell, R. Clark, R. Watanabe, and T. Kupper, Sezary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviors, Blood, vol.116, issue.5, pp.767-771, 2010.
DOI : 10.1182/blood-2009-11-251926

URL : http://www.bloodjournal.org/content/bloodjournal/116/5/767.full.pdf

E. Campo, S. Swerdlow, and N. Harris, The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications, Blood, vol.117, issue.19, pp.5019-5032, 2011.
DOI : 10.1182/blood-2011-01-293050

URL : http://www.bloodjournal.org/content/bloodjournal/117/19/5019.full.pdf

E. Capriotti, E. Vonderheid, and C. Thoburn, Chemokine Receptor Expression by Leukemic T Cells of Cutaneous T-Cell Lymphoma: Clinical and Histopathological Correlations, Journal of Investigative Dermatology, vol.127, issue.12, pp.2882-2892, 2007.
DOI : 10.1038/sj.jid.5700916

URL : https://doi.org/10.1038/sj.jid.5700916

T. Chou, Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies, Pharmacological Reviews, vol.58, issue.3, pp.621-681, 2006.
DOI : 10.1124/pr.58.3.10

URL : http://pharmrev.aspetjournals.org/content/pharmrev/58/3/621.full.pdf

E. Contassot, K. Kerl, and S. Roques, Resistance to FasL and tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in Sezary syndrome T-cells associated with impaired death receptor and FLICE-inhibitory protein expression, Blood, vol.111, issue.9, pp.4780-47879, 2008.
DOI : 10.1182/blood-2007-08-109074

URL : http://www.bloodjournal.org/content/bloodjournal/111/9/4780.full.pdf

R. Costello, C. Sanchez, L. Treut, and T. , Peripheral T-cell lymphoma gene expression profiling and potential therapeutic exploitations, British Journal of Haematology, vol.102, issue.Suppl. 5, pp.21-27, 2010.
DOI : 10.1182/blood-2002-11-3574

URL : https://hal.archives-ouvertes.fr/hal-01595909

A. Dalloul, L. Laroche, and M. Bagot, Interleukin-7 is a growth factor for S??zary lymphoma cells., Journal of Clinical Investigation, vol.90, issue.3, pp.1054-1060, 1992.
DOI : 10.1172/JCI115920

URL : http://www.jci.org/articles/view/115920/files/pdf

G. Didier, P. Brézellec, R. E. Hénaut, and A. , GeneANOVA--gene expression analysis of variance, Bioinformatics, vol.18, issue.3, pp.490-49112, 2002.
DOI : 10.1093/bioinformatics/18.3.490

URL : https://hal.archives-ouvertes.fr/hal-01614111

M. Duvic and J. Vu, Vorinostat: a new oral histone deacetylase inhibitor approved for cutaneous T-cell lymphoma, Expert Opinion on Investigational Drugs, vol.19, issue.7, pp.1111-1120, 2007.
DOI : 10.1038/nrd2133

J. Gardner, C. Introcaso, and S. Nasta, A novel regimen of vorinostat with interferon gamma for refractory S??zary syndrome, Journal of the American Academy of Dermatology, vol.61, issue.1, pp.112-116, 2009.
DOI : 10.1016/j.jaad.2008.11.889

V. Gotea and I. Ovcharenko, DiRE: identifying distant regulatory elements of co-expressed genes, Nucleic Acids Research, vol.14, issue.6, pp.133-139, 2008.
DOI : 10.1101/gr.849004

URL : https://academic.oup.com/nar/article-pdf/36/suppl_2/W133/7628835/gkn300.pdf

D. Huang, B. Sherman, and R. Lempicki, Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists, Nucleic Acids Research, vol.8, issue.1, pp.1-13, 2009.
DOI : 10.1186/1471-2105-8-9

URL : https://academic.oup.com/nar/article-pdf/37/1/1/17059338/gkn923.pdf

D. Huang, B. Sherman, and R. Lempicki, Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources, Nature Protocols, vol.99, issue.1, pp.44-57, 2009.
DOI : 10.6026/97320630002428

L. Huang, Y. Sowa, T. Sakai, and A. Pardee, Activation of the p21WAF1/CIP1 promoter independent of p53 by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through the Sp1 sites, Oncogene, vol.19, issue.50, pp.5712-5719, 2000.
DOI : 10.1073/pnas.93.23.12845

N. Iraci, D. Diolaiti, and A. Papa, A SP1/MIZ1/MYCN Repression Complex Recruits HDAC1 at the TRKA and p75NTR Promoters and Affects Neuroblastoma Malignancy by Inhibiting the Cell Response to NGF, Cancer Research, vol.71, issue.2, pp.404-412, 2011.
DOI : 10.1158/0008-5472.CAN-10-2627

URL : http://cancerres.aacrjournals.org/content/canres/71/2/404.full.pdf

L. Kari, A. Loboda, and M. Nebozhyn, Classification and Prediction of Survival in Patients with the Leukemic Phase of Cutaneous T Cell Lymphoma, The Journal of Experimental Medicine, vol.112, issue.11, pp.1477-1488, 2003.
DOI : 10.1517/13543784.9.12.2767

T. Krejsgaard, N. Odum, and C. Geisler, Regulatory T cells and immunodeficiency in mycosis fungoides and S??zary syndrome, Leukemia, vol.102, issue.3, pp.424-432, 2012.
DOI : 10.1182/blood-2003-04-1044

E. Kim, S. Hess, and S. Richardson, Immunopathogenesis and therapy of cutaneous T cell lymphoma, Journal of Clinical Investigation, vol.115, issue.4, pp.798-812, 2005.
DOI : 10.1172/JCI24826DS1

S. Kim, N. Kim, and W. Lee, Histone Deacetylase Inhibitor Induction of P-Glycoprotein Transcription Requires Both Histone Deacetylase 1 Dissociation and Recruitment of CAAT/Enhancer Binding Protein ?? and pCAF to the Promoter Region, Molecular Cancer Research, vol.7, issue.5, pp.735-744, 2009.
DOI : 10.1158/1541-7786.MCR-08-0296

C. Lee, A. Ungewickell, and A. Bhaduri, Transcriptome sequencing in Sezary syndrome identifies Sezary cell and mycosis fungoides-associated lncRNAs and novel transcripts, Blood, vol.120, issue.16, pp.3288-3297, 2012.
DOI : 10.1182/blood-2012-04-423061

URL : http://www.bloodjournal.org/content/bloodjournal/120/16/3288.full.pdf

K. Livak and T. Schmittgen, Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method, pp.402-408, 2001.
DOI : 10.1006/meth.2001.1262

M. Mir, S. Majee, S. Das, and D. Dasgupta, Association of chromatin with anticancer antibiotics, mithramycin and chromomycin A 3, Bioorganic & Medicinal Chemistry, vol.11, issue.13, pp.2791-2801, 2003.
DOI : 10.1016/S0968-0896(03)00211-6

A. Nakayama, T. Odajima, and H. Murakami, Characterization of two promoters that regulate alternative transcripts in the microtubule-associated protein (MAP) 1A gene, Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression, vol.1518, issue.3, pp.260-266, 2001.
DOI : 10.1016/S0167-4781(01)00173-7

M. Narducci, E. Scala, and A. Bresin, Skin homing of Sezary cells involves SDF-1-CXCR4 signaling and down-regulation of CD26/dipeptidylpeptidase IV, Blood, vol.107, issue.3, pp.1108-1115, 2006.
DOI : 10.1182/blood-2005-04-1492

URL : http://www.bloodjournal.org/content/bloodjournal/107/3/1108.full.pdf

M. Ritchie, B. Phipson, and D. Wu, limma powers differential expression analyses for RNA-sequencing and microarray studies, Nucleic Acids Research, vol.15, issue.7, p.47, 2015.
DOI : 10.1186/s13059-014-0465-4

URL : https://academic.oup.com/nar/article-pdf/43/7/e47/7207289/gkv007.pdf

S. Rivero, A. Ruiz-garcía, and M. Díaz-guerra, Characterization of a proximal Sp1 response element in the mouse Dlk2 gene promoter, BMC Molecular Biology, vol.12, issue.1, p.52, 2011.
DOI : 10.1186/1471-2199-12-52

Y. Shao, Z. Gao, P. Marks, and X. Jiang, Apoptotic and autophagic cell death induced by histone deacetylase inhibitors, Proceedings of the National Academy of Sciences, vol.98, issue.19, pp.18030-18035, 2004.
DOI : 10.1073/pnas.191208598

URL : http://www.pnas.org/content/101/52/18030.full.pdf

M. Tajrishi, J. Shin, M. Hetman, and A. Kumar, DNA Methyltransferase 3a and Mitogen-activated Protein Kinase Signaling Regulate the Expression of Fibroblast Growth Factor-inducible 14 (Fn14) during Denervation-induced Skeletal Muscle Atrophy, Journal of Biological Chemistry, vol.13, issue.29, pp.19985-19999, 2014.
DOI : 10.1016/S0002-9440(10)64996-6

URL : http://www.jbc.org/content/289/29/19985.full.pdf

M. Wozniak, R. Villuendas, and J. Bischoff, Vorinostat interferes with the signaling transduction pathway of T-cell receptor and synergizes with phosphoinositide-3 kinase inhibitors in cutaneous T-cell lymphoma, Haematologica, vol.95, issue.4, pp.613-621, 2010.
DOI : 10.3324/haematol.2009.013870

J. Wu, M. Nihal, and J. Siddiqui, Low FAS/CD95 Expression by CTCL Correlates with Reduced Sensitivity to Apoptosis that Can Be Restored by FAS Upregulation, Journal of Investigative Dermatology, vol.129, issue.5, pp.1165-1173, 2009.
DOI : 10.1038/jid.2008.309

URL : https://doi.org/10.1038/jid.2008.309

Q. Zhang, I. Nowak, and E. Vonderheid, Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome., Proceedings of the National Academy of Sciences, vol.93, issue.17, pp.9148-9153, 1996.
DOI : 10.1073/pnas.93.17.9148